Diabetes, Obesity and Metabolism Diabetes, Obesity and Metabolism RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin ‐naive individuals with type 2 diabetes mellitus
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 23, 2018 Category: Endocrinology Authors: Brian M. Frier MD , Wolfgang Landgraf PhD , Mei Zhang PhD , Geremia B. Bolli MD , David R. Owens MD Source Type: research

Outcomes of “diabetes‐friendly” vs “diabetes‐unfriendly” β‐blockers in older nursing home residents with diabetes after acute myocardial infarction
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 23, 2018 Category: Endocrinology Authors: Andrew R. Zullo PhD , Michelle Hersey PharmD , Yoojin Lee MS , Sadia Sharmin MBBS , Elliott Bosco PharmD , Lori A. Daiello PharmD , Nishant R. Shah MD , Vincent Mor PhD , W. John Boscardin PhD , Christine M. Berard ‐ Source Type: research

Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1 ‐year prospective observational study with suggestions to minimize clinical impact
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 19, 2018 Category: Endocrinology Authors: Ivana Rabbone MD , Nicola Minuto MD , Sonia Toni MD , Fortunato Lombardo MD , Dario Iafusco MD , Marco Marigliano MD , Riccardo Schiaffini MD , Giulio Maltoni MD , Anna P. Frongia MD , Marco Scardapane MD , Antonio Source Type: research

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 19, 2018 Category: Endocrinology Authors: Revital Nimri MD , Eyal Dassau PhD , Tomer Segall BSc , Ido Muller BSc , Natasa Bratina MD , Olga Kordonouri MD , Rachel Bello MD , Torben Biester MD , Klemen Dovc MD , Ariel Tenenbaum MD , Avivit Brener MD , Source Type: research

A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT ‐R Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 18, 2018 Category: Endocrinology Authors: Russell Scott MD, PhD , Jerry Morgan BS , Zachary Zimmer PhD , Raymond L.H. Lam PhD , Edward A. O ’Neill PhD , Keith D. Kaufman MD , Samuel S. Engel MD , Annaswamy Raji MD Source Type: research

Dissection of hepatic vs. extra ‐hepatic insulin clearance: ethnic differences in childhood
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 18, 2018 Category: Endocrinology Authors: Francesca Piccinini PhD , David C. Polidori PhD , Barbara A. Gower PhD , Jose R. Fernandez PhD , Richard N. Bergman PhD Source Type: research

Dapagliflozin, a sodium ‐glucose co‐transporter‐2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 17, 2018 Category: Endocrinology Authors: Krit Jaikumkao PhD , Anchalee Pongchaidecha PhD , Nuttawud Chueakula MS , La ‐ongdao Thongnak MS , Keerati Wanchai PhD , Varanuj Chatsudthipong PhD , Nipon Chattipakorn MD , Anusorn Lungkaphin PhD Source Type: research

Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300  U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12‐month comparison by concomitant sulphonylurea and/or glinide use
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 17, 2018 Category: Endocrinology Authors: Yasuo Terauchi MD , Matthew C. Riddle MD , Takahisa Hirose MD , Masayoshi Koyama , Xi Cheng , Yoshinori Takahashi , Geremia B. Bolli MD Source Type: research

Effect of once ‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 17, 2018 Category: Endocrinology Authors: Stefan Korsatko MD , Lene Jensen PhD , Martina Brunner MSc , Stefanie Sach ‐Friedl MSc , Maja D. Tarp MSc , Anders G. Holst MD , Simon R. Heller MD , Thomas R. Pieber MD Source Type: research

Triglyceride ‐rich very low density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 13, 2018 Category: Endocrinology Authors: Domenico Tric ò MD , Andrea Natali MD , Andrea Mari PhD , Ele Ferrannini MD , Nicola Santoro MD, PhD , Sonia Caprio MD Source Type: research

Observational research on sodium glucose co ‐transporter 2 inhibitors: a real breakthrough?
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 13, 2018 Category: Endocrinology Authors: Emanuel Raschi , Elisabetta Poluzzi , Gian Paolo Fadini , Giulio Marchesini , Fabrizio De Ponti Source Type: research

Glycemic control and hypoglycemia benefits with insulin glargine 300 U/mL (Gla ‐300) extend to people with type 2 diabetes and mild‐to‐moderate renal impairment
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 13, 2018 Category: Endocrinology Authors: F. Javier Escalada MD , Serge Halimi MD , Peter A. Senior MBBS PhD , Mireille Bonnemaire MD , Anna MG Cali MD , Lydie Melas ‐Melt , Janaka Karalliedde MBBS MRCP PhD , Robert A. Ritzel MD Source Type: research

Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 13, 2018 Category: Endocrinology Authors: David G Bruce , Wendy A Davis , Timothy ME Davis Source Type: research

Ultra ‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 13, 2018 Category: Endocrinology Authors: Grit Andersen MD , Gr égory Meiffren PhD , Daniela Lamers PhD , J. Hans DeVries MD , Aymeric Ranson MSc , Cyril Seroussi MSc , Bertrand Alluis PhD , Martin Gaudier PhD , Olivier Soula PhD , Tim Heise MD Source Type: research

Short ‐term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo‐controlled, double blind, cross‐over pilot study
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - July 12, 2018 Category: Endocrinology Authors: Andreas Melmer MD , Patrick Kempf MD , Lukas Lunger MD , Thomas R. Pieber MD , Julia K. Mader MD , Christoph Stettler MD , Herbert Tilg MD , Christoph F. Ebenbichler MD , Markus Laimer MD Source Type: research